BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16325241)

  • 1. Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women.
    Rieck GC; Bhaumik J; Beer HR; Leeson SC
    Gynecol Oncol; 2006 May; 101(2):228-33. PubMed ID: 16325241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of repeat Pap smear at the time of initial colposcopy.
    Spitzer M; Ryskin M; Chernys AE; Shifrin A
    Gynecol Oncol; 1997 Oct; 67(1):3-7. PubMed ID: 9345348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of cervical cytology in HIV-infected women.
    Del Priore G; Maag T; Bhattacharya M; Garcia PM; Till M; Lurain JR
    Gynecol Oncol; 1995 Mar; 56(3):395-8. PubMed ID: 7705674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of outcome in women with borderline glandular change on cervical cytology.
    Jadoon BA; Kehoe S; Romain K; Clelland C; Sundar SS
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):83-5. PubMed ID: 19740591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopy.
    Lonky NM; Mann WJ; Massad LS; Mutch DG; Blanco JS; Vasilev SA; Finan MA; Scotti RJ
    J Reprod Med; 1995 Jul; 40(7):530-6. PubMed ID: 7473444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of normal colposcopy after an abnormal cervical smear report.
    Luesley D; Downey G
    J Low Genit Tract Dis; 2009 Jan; 13(1):33-7. PubMed ID: 19098604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
    J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
    Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
    J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HPV testing in patients with possible high-grade cervical cytology.
    Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
    J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
    Walker JL; Wang SS; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the accuracy of colposcopy at predicting the outcome of abnormal cytology in pregnancy.
    Siddiq TS; Twigg JP; Hammond RH
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):93-7. PubMed ID: 16029922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a low priced liquid-based method for cervical cytology in 632 women referred for colposcopy after a positive Pap smear.
    van Hemel BM; Buikema HJ; Groen H; Suurmeijer AJ
    Diagn Cytopathol; 2009 Aug; 37(8):579-83. PubMed ID: 19373881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.